Smith Salley Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-24,275
Closed -$3.24M 182
2018
Q4
$3.24M Sell
24,275
-12,951
-35% -$2.12M 0.6% 58
2018
Q3
$7.09M Buy
37,226
+1,990
+6% +$366K 1.12% 33
2018
Q2
$5.88M Buy
35,236
+420
+1% +$67.4K 1.01% 39
2018
Q1
$5.86M Buy
34,816
+1,958
+6% +$328K 1.05% 38
2017
Q4
$5.38M Sell
32,858
-691
-2% -$124K 0.96% 37
2017
Q3
$6.88M Buy
33,549
+563
+2% +$131K 1.32% 25
2017
Q2
$8.02M Buy
32,986
+145
+0.4% +$34.1K 1.61% 16
2017
Q1
$7.85M Sell
32,841
-527
-2% -$123K 1.61% 16
2016
Q4
$7.01M Sell
33,368
-1,057
-3% -$219K 1.46% 20
2016
Q3
$7.93M Sell
34,425
-123
-0.4% -$30.1K 1.76% 13
2016
Q2
$7.98M Buy
34,548
+8,740
+34% +$2.02M 1.86% 13
2016
Q1
$6.92M Buy
25,808
+4,868
+23% +$1.39M 1.73% 14
2015
Q4
$6.54M Buy
20,940
+670
+3% +$199K 1.63% 15
2015
Q3
$5.51M Buy
20,270
+859
+4% +$264K 1.49% 21
2015
Q2
$5.89M Buy
19,411
+10,044
+107% +$3M 1.5% 20
2015
Q1
$2.79M Buy
+9,367
New +$2.67M 0.71% 49

Other funds holding AGN

Smith Salley Wealth Management's AGN Position: Q1 2019 in Review

Smith Salley Wealth Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 24,275 shares — an estimated $3.24M sold.

Smith Salley Wealth Management first reported a position in AGN in Q1 2015 and held it in 16 quarters. The position peaked at $8.02M in Q2 2017. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Smith Salley Wealth Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Smith Salley Wealth Management sold 24,275 Allergan plc shares in Q1 2019, an estimated $3.24M.
  • Smith Salley Wealth Management first reported a position in Allergan plc in Q1 2015 and held it in 16 quarters.
  • Smith Salley Wealth Management's Allergan plc position peaked at $8.02M in Q2 2017.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Smith Salley Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.